BioLytical Laboratories
Company profile
Primary focus
Manufacturer of rapid point-of-care in vitro diagnostic tests focused on infectious diseases.
Why it’s included
The company develops and manufactures multiple rapid point-of-care lateral-flow and multiplex immunoassays for infectious-disease antigen and antibody detection, as evidenced by named products such as the 'iStatis lateral-flow platform' and 'INSTI Multiplex Ab' for HIV, hepatitis, syphilis, and COVID-19.
Relevant capabilities
- Proprietary flow-through immunoassay platform
- Lateral-flow immunoassay platform development
- Rapid point-of-care diagnostic test development
- Antibody and antigen immunoassay design (IgG/IgM)
- Multiplex assay development
Commercial sectorInstrument-free lateral flow and rapid tests
Technology classesConventional antibody lateral flow and rapid immunoassays
Relevant commercial products
- iStatis lateral-flow platform
- INSTI Multiplex Ab
- Multiplex HIV-1/2 and Syphilis Antibody Test
- iStatis COVID-19 Antigen Test (professional)
- INSTI 4 HCV Antibody Test
Relevant patents
1 family, 1 publication- Methods and rapid test kits facilitating epidemiological surveillance US-11011278-B1